$ICDIQ
Independence Contract Drilling, Inc.

2024 Q2 Form 10-Q Financial Statement

#000153702824000015 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $43.33M $46.64M
YoY Change -23.12% -26.85%
Cost Of Revenue $31.54M $30.82M
YoY Change -6.78% -17.74%
Gross Profit $11.79M $15.82M
YoY Change -47.66% -39.84%
Gross Profit Margin 27.22% 33.92%
Selling, General & Admin $3.731M $4.337M
YoY Change -28.58% -35.53%
% of Gross Profit 31.64% 27.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.57M $11.83M
YoY Change 10.22% 8.96%
% of Gross Profit 106.61% 74.75%
Operating Expenses $3.731M $16.16M
YoY Change -77.56% 140.27%
Operating Profit -$7.679M -$343.0K
YoY Change -230.15% -103.93%
Interest Expense -$10.25M -$9.878M
YoY Change 24.17% 13.29%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$17.92M -$9.217M
YoY Change 311.29% -92270.0%
Income Tax -$1.207M -$231.0K
% Of Pretax Income
Net Earnings -$16.72M -$8.986M
YoY Change 301.75% -74983.33%
Net Earnings / Revenue -38.58% -19.27%
Basic Earnings Per Share -$1.15 -$0.62
Diluted Earnings Per Share -$1.15 -$0.62
COMMON SHARES
Basic Shares Outstanding 15.21M 15.27M
Diluted Shares Outstanding 14.52M 14.50M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.542M $6.944M
YoY Change -0.75% 3.41%
Cash & Equivalents $5.542M $6.944M
Short-Term Investments
Other Short-Term Assets $2.369M $3.697M
YoY Change -13.29% 369600.0%
Inventory $1.528M $1.570M
Prepaid Expenses
Receivables $30.45M $27.19M
Other Receivables $0.00 $0.00
Total Short-Term Assets $39.89M $39.40M
YoY Change -10.33% -26.99%
LONG-TERM ASSETS
Property, Plant & Equipment $334.6M $342.7M
YoY Change -10.77% -9.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.279M $2.670M
YoY Change 173.92% 11.76%
Total Long-Term Assets $335.1M $345.4M
YoY Change -10.83% -9.37%
TOTAL ASSETS
Total Short-Term Assets $39.89M $39.40M
Total Long-Term Assets $335.1M $345.4M
Total Assets $375.0M $384.8M
YoY Change -10.78% -11.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.72M $18.80M
YoY Change 13.2% -30.25%
Accrued Expenses $7.770M $6.378M
YoY Change 8.87% -52.93%
Deferred Revenue $401.0K $614.0K
YoY Change -63.18% -55.12%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.400M $1.525M
YoY Change -28.09% -26.36%
Total Short-Term Liabilities $29.89M $30.11M
YoY Change -6.78% -29.28%
LONG-TERM LIABILITIES
Long-Term Debt $170.9M $170.4M
YoY Change 10.12% 3.95%
Other Long-Term Liabilities $8.131M $1.316M
YoY Change -1.75% 101.84%
Total Long-Term Liabilities $8.131M $171.7M
YoY Change -95.03% 26233.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.89M $30.11M
Total Long-Term Liabilities $8.131M $171.7M
Total Liabilities $217.3M $211.3M
YoY Change 4.73% -3.67%
SHAREHOLDERS EQUITY
Retained Earnings -$462.5M -$445.8M
YoY Change 14.69% 11.7%
Common Stock $624.3M $623.3M
YoY Change 0.7% 0.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $157.7M $173.4M
YoY Change
Total Liabilities & Shareholders Equity $375.0M $384.8M
YoY Change -10.78% -11.56%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$16.72M -$8.986M
YoY Change 301.75% -74983.33%
Depreciation, Depletion And Amortization $12.57M $11.83M
YoY Change 10.22% 8.96%
Cash From Operating Activities $6.462M $11.00M
YoY Change -69.94% -18.87%
INVESTING ACTIVITIES
Capital Expenditures $7.337M $9.974M
YoY Change -40.49% -47.05%
Acquisitions
YoY Change
Other Investing Activities $1.833M $1.783M
YoY Change 129.7% 138.37%
Cash From Investing Activities -$5.504M -$8.191M
YoY Change -52.27% -54.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.360M -1.429M
YoY Change -78.73% -124.15%
NET CHANGE
Cash From Operating Activities 6.462M 11.00M
Cash From Investing Activities -5.504M -8.191M
Cash From Financing Activities -2.360M -1.429M
Net Change In Cash -1.402M 1.379M
YoY Change 23.96% -0.72%
FREE CASH FLOW
Cash From Operating Activities $6.462M $11.00M
Capital Expenditures $7.337M $9.974M
Free Cash Flow -$875.0K $1.025M
YoY Change -109.55% -119.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3697000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4759000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
39399000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
43576000
CY2024Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
342701000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
348193000
CY2023Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001537028
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2024Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2024Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2024Q1 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-36590
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Independence Contract Drilling, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1653648
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
20475 State Highway 249
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77070
CY2024Q1 dei City Area Code
CityAreaCode
281
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
598-1230
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2024Q1 dei Trading Symbol
TradingSymbol
ICD
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15213277
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6944000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5565000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27188000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31695000
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1570000
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1557000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2670000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2908000
CY2024Q1 us-gaap Assets
Assets
384770000
CY2023Q4 us-gaap Assets
Assets
394677000
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1525000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1226000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
18800000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
22990000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9783000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16371000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
30108000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40587000
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
170378000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
154549000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9521000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9761000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1316000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8201000
CY2024Q1 us-gaap Liabilities
Liabilities
211323000
CY2023Q4 us-gaap Liabilities
Liabilities
213098000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15369536
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14523124
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15213277
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14425864
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
152000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
144000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
623174000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
622169000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-445780000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-436794000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
156259
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
97260
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
4099000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
3940000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
173447000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
181579000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
384770000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
394677000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46636000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63756000
CY2024Q1 us-gaap Direct Operating Costs
DirectOperatingCosts
30816000
CY2023Q1 us-gaap Direct Operating Costs
DirectOperatingCosts
37460000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4337000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6727000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11826000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10854000
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1004000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
14000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
45975000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
55027000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
661000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8729000
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9878000
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8719000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9217000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-231000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8986000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14504000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13865000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14504000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13881000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
181579000
CY2024Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-12000
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
160000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1026000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8986000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
173447000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
214712000
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-385000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-34000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1374000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
215679000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-8986000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
12000
CY2024Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
11826000
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
10854000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
216000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1672000
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1004000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
14000
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
6487000
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
11619000
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
27000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
27000
CY2024Q1 icd Amortization Of Convertible Notes Issuance Costs And Debt Discount
AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount
2720000
CY2022Q1 icd Market Price Of Oil
MarketPriceOfOil
123.64
CY2024Q2 icd Market Price Of Oil
MarketPriceOfOil
83.82
CY2023Q1 icd Amortization Of Convertible Notes Issuance Costs And Debt Discount
AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount
2378000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-231000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-13000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
31000
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4507000
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2094000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
35000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1208000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-324000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5758000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11203000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10999000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13558000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9974000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18835000
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1783000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
748000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8191000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18087000
CY2024Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3500000
CY2024Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
19624000
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
11321000
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
16874000
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
4334000
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-34000
CY2024Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
160000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
385000
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
507000
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
650000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1429000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5918000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1379000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1389000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5565000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5326000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6944000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6715000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
549000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
419000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
110000
CY2024Q1 icd Change In Property Plant And Equipment Purchases In Accounts Payable
ChangeInPropertyPlantAndEquipmentPurchasesInAccountsPayable
-4135000
CY2023Q1 icd Change In Property Plant And Equipment Purchases In Accounts Payable
ChangeInPropertyPlantAndEquipmentPurchasesInAccountsPayable
-5091000
CY2024Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1513000
CY2023Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
51000
CY2024Q1 icd Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets
FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets
304000
CY2022Q3 icd Natural Gas Price
NaturalGasPrice
9.85
CY2022Q4 icd Natural Gas Price
NaturalGasPrice
3.52
CY2023 icd Natural Gas Price
NaturalGasPrice
2.58
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46636000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
63756000
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2024Q1 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
26869000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
31380000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
614000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
578000
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
431000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1375000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2131000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
540000
CY2024Q1 icd Contract With Customer Liability Increase Decrease From Cash Receipts
ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts
467000
CY2023Q1 icd Contract With Customer Liability Increase Decrease From Cash Receipts
ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts
751000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
614000
CY2024Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
600000
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
500000
CY2024Q1 icd Capitalized Contract Cost Increase
CapitalizedContractCostIncrease
1100000
CY2024Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1000000.0
CY2023Q1 icd Capitalized Contract Cost Increase
CapitalizedContractCostIncrease
900000
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
500000
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
299000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
191000
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2143000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1730000
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
127000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
162000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
467000
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
555000
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
73000
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
73000
CY2024Q1 icd Finance Lease Cost
FinanceLeaseCost
540000
CY2023Q1 icd Finance Lease Cost
FinanceLeaseCost
628000
CY2024Q1 us-gaap Lease Cost
LeaseCost
3109000
CY2023Q1 us-gaap Lease Cost
LeaseCost
2711000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
253000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
196000
CY2024Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
73000
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
73000
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
507000
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
650000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
75000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
618000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1513000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
51000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2029000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2205000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
889000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
934000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1242000
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2996000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
614000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2309000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
5931000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
6238000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
1734000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
1829000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
4197000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
4409000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1525000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1226000
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2204000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1659000
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
3729000
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
2885000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2024Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0860
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0875
CY2024Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0795
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0825
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
840000
CY2024Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
1395000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
540000
CY2024Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1486000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
401000
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1118000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
370000
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
97000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
285000
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2436000
CY2024Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
4096000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
305000
CY2024Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
367000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2131000
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
3729000
CY2024Q1 icd Fair Value Assets Level Transfers Amount
FairValueAssetsLevelTransfersAmount
0
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
2390000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3502000
CY2024Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
591000
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
467000
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
716000
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
790000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3697000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4759000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2643000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6625000
CY2024Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1859000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
578000
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1617000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2124000
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
46000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
25000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
889000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
934000
CY2024Q1 icd Accrued Liabilities Time Based Cash Settled Stock Appreciation Rights
AccruedLiabilitiesTimeBasedCashSettledStockAppreciationRights
1183000
CY2023Q4 icd Accrued Liabilities Time Based Cash Settled Stock Appreciation Rights
AccruedLiabilitiesTimeBasedCashSettledStockAppreciationRights
2054000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
932000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1035000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9783000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16371000
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
3729000
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
2885000
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
201002000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
187594000
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
29099000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
31819000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1525000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1226000
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
170378000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
154549000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
216000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1672000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
33332
CY2024Q1 us-gaap Shares Outstanding
SharesOutstanding
15213277
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
156259
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8986000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14504000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13865000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14504000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13881000
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40453000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39230000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.025
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.200
CY2024Q1 us-gaap Purchase Obligation
PurchaseObligation
5100000
CY2022Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
78900000
CY2022Q1 icd Investor S Rights Agreement Number Of Directors Who Can Be Nominated
InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated
1
CY2022Q1 icd Investors Rights Agreement Principal Amount
InvestorsRightsAgreementPrincipalAmount
25000000.0
CY2022Q1 icd Investor S Rights Agreement Number Of Directors Who Can Be Nominated
InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated
1
CY2022Q1 icd Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director
NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector
2
CY2022Q1 icd Number Of Additional Representative To Be Appointed As Individual Director
NumberOfAdditionalRepresentativeToBeAppointedAsIndividualDirector
1
CY2022Q1 icd Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director
NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector
2
CY2022Q1 icd Number Of Directors
NumberOfDirectors
6
CY2022Q3 icd Number Of Directors
NumberOfDirectors
7
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001537028-24-000015-index-headers.html Edgar Link pending
0001537028-24-000015-index.html Edgar Link pending
0001537028-24-000015.txt Edgar Link pending
0001537028-24-000015-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
icd-20240331.xsd Edgar Link pending
icd-20240331x10q.htm Edgar Link pending
icd-20240331xex10d1.htm Edgar Link pending
icd-20240331xex10d2.htm Edgar Link pending
icd-20240331xex10d2001.jpg Edgar Link pending
icd-20240331xex10d3.htm Edgar Link pending
icd-20240331xex10d3001.jpg Edgar Link pending
icd-20240331xex10d4.htm Edgar Link pending
icd-20240331xex31d1.htm Edgar Link pending
icd-20240331xex31d2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
icd-20240331x10q_htm.xml Edgar Link completed
icd-20240331xex32d1.htm Edgar Link pending
icd-20240331xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
icd-20240331_def.xml Edgar Link unprocessable
icd-20240331_lab.xml Edgar Link unprocessable
icd-20240331_pre.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
icd-20240331_cal.xml Edgar Link unprocessable